AMERICAN INTERNATIONAL GROUP, INC. - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$70,946
-21.8%
16,892
+3.7%
0.00%
-100.0%
Q2 2023$90,746
+212.9%
16,292
+128.1%
0.00%
Q1 2022$29,000
-44.2%
7,144
-6.6%
0.00%
Q4 2021$52,000
-42.9%
7,647
-2.9%
0.00%
Q3 2021$91,000
-33.6%
7,875
-2.3%
0.00%
Q2 2021$137,000
-1.4%
8,062
+15.0%
0.00%
Q1 2021$139,000
+41.8%
7,011
+48.4%
0.00%
Q4 2020$98,000
-23.4%
4,724
-2.8%
0.00%
-100.0%
Q3 2020$128,0004,8600.00%
Other shareholders
INOZYME PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,591,154$10,852,0004.54%
CHI Advisors LLC 892,057$6,084,0002.02%
Sofinnova Investments, Inc. 2,028,308$13,833,0000.81%
MPM BioImpact LLC 302,615$2,064,0000.38%
NEA Management Company, LLC 2,444,379$16,671,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,344,786$15,991,0000.34%
Rock Springs Capital Management LP 868,466$5,923,0000.14%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,013,216$6,910,0000.13%
Orbimed Advisors 526,600$3,591,0000.05%
Overbrook Management Corp 16,726$114,0000.02%
View complete list of INOZYME PHARMA INC shareholders